Life Sciences
96 results total, viewing 31 - 40
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the six winners of its inaugural Rhode Island Bioscience Awards. more
When the Brown University researchers who formed BrainGate Co. enabled a paralyzed woman to operate a robotic arm through thought, scientists around the world heard about the breakthrough developed in Providence. more
Four months ago, when Denice Spero, co-director of iCubed, the Institute for Immunology and Immunization, hosted scientists from around the world at the sixth annual Vaccine Renaissance Conference at Hotel Providence in October 2012, it attracted scant attention from the local business community. more
he Rhode Island Tech Collective announced last week that “science-centric” comedian Brian Malow is slated to perform at its inaugural Bioscience Awards celebration. more
Research spending at the University of Massachusetts in fiscal year 2012 surpassed the $500 million mark for the third consecutive year, UMass President Robert L. Caret announced Wednesday. more
Dr. Jennifer Friedman, a pediatrician at Hasbro Children’s Hospital and director of clinical studies for the Center for International Health Research at Rhode Island, was awarded the 2012 Bruce M. Selya Award for excellence in research by Lifespan. more
Medical technology maker Covidien PLC reported first-quarter earnings of $493 million, or $1.03 per diluted share, a slight decrease from the $494 million, or $1.02 per diluted share, reported for the first-quarter of its fiscal 2012. more
Pharmaceutical developer Collegium Pharmaceutical Inc. has moved its operations out of Cumberland to more refined labs Canton, Mass., the company announced Thursday. more
On Wednesday evening, Stephen Lane - chairman, chief venture officer and co-founder of Ximedica - played host to a diverse group of more than 40 members of Rhode Island's emerging med-tech community to discuss strategies to enhance connectivity and collaboration. more
Amgen Inc., one of the world’s biggest biotechnology companies, will spend as much as $180.5 million for the right to develop cancer drugs using nanotechnology from closely held Bind Biosciences. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 10 | Next »
Calendar
PBN Hosted
Events

The 2nd Annual Healthiest Employers event will recognize employers who have strong, effective Health and Wellness programs in the region. Deadline for enrollment is June 28th.
Advertisement
National
Local
Latest News